NDC 0409-1312 – Hydromorphone Hydrochloride

Hydromorphone Hydrochloride 2 mg/mL · Injection, Solution · Intramuscular, Intravenous, Subcutaneous

Human Prescription Drug DEA schedule CII 3 recalls

Product NDC0409-1312

Product details

Brand name
Hydromorphone Hydrochloride
Generic name
Hydromorphone Hydrochloride
Labeler
Hospira, Inc.
Dosage form
Injection, Solution
Route
Intramuscular, Intravenous, Subcutaneous
Marketing category
NDA · NDA200403
Marketed since
February 1, 2021
Listing expires
December 31, 2027
Pharmacologic class
Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Hydromorphone Hydrochloride →

Package NDC codes (2)

Package NDCDescriptionSince
0409-1312-3010 CARTRIDGE in 1 CARTON (0409-1312-30) / 1 mL in 1 CARTRIDGE (0409-1312-03)Dec 1, 2011
0409-1312-3610 SYRINGE in 1 CELLO PACK (0409-1312-36) / 1 mL in 1 SYRINGE (0409-1312-16)Feb 1, 2021

Recalls mentioning this NDC

Other Hydromorphone Hydrochloride products